Asset Dedication, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Asset Dedication, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	BUY	$185.53 - $241.31 $185 - $241	1 New	1 $0
Q4 2021 Jan 21, 2022	SELL	$159.56 - $209.29 $2,552 - $3,348	-16 Closed	0 $0
Q3 2021 Oct 18, 2021	BUY	$169.75 - $207.73 $2,716 - $3,323	16 New	16 $3,000
Q2 2018 Aug 13, 2018	SELL	$88.31 - $107.8 $6,623 - $8,085	-75 Closed	0 $0
Q1 2018 Apr 19, 2018	BUY	$115.92 - $148.54 $8,694 - $11,140	75 New	75 $9,000

643

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

Stay updated on Asset Dedication, LLC with notifications on news.